The Buddhist Compassion Relief Tzu Chi Foundation’s application to import 5 million doses of the BioNTech COVID-19 vaccine will not be considered alongside similar requests tendered by the Yonglin Foundation and Taiwan Semiconductor Manufacturing Co (TSMC) due to differences in their applications, Executive Yuan spokesperson Lo Ping-cheng (羅秉成) said yesterday.
The Tzu Chi Foundation on Wednesday submitted an application to the Food and Drug Administration (FDA), after the Executive Yuan on Friday last week authorized the YongLin Foundation and TSMC to represent the government to purchase vaccines from BioNTech.
After evaluations, the proposals by TSMC and the YongLin Foundation are more feasible and have a greater “chance” of success, Lo told a news conference at the Executive Yuan in Taipei.
Photo courtesy of the Buddhist Compassion Relief Tzu Chi Foundation
The Tzu Chi Foundation’s application is not being merged with the other two due to differences with each application, he said, without elaborating.
International purchases of vaccines are complicated and it is vital to develop a model that has a greater chance of success, Lo said.
None of the applications included an “authorization notice” from the original manufacturer, BioNTech.
It is rare that the first tender of an application includes a manufacturer’s authorization, FDA Director-General Wu Shou-mei (吳秀梅) said on Wednesday, adding that it would look into the Tzu Chi Foundation’s application and ask it to provide any missing documents.
The Tzu Chi Foundation has said that it cannot obtain the manufacturer’s authorization unless the government first approves its application.
Tzu Chi Foundation executive director Yen Po-wen (顏博文) said that it has followed the government regulations and would do its best to provide whatever documents are required.
Should a purchase proceed, vaccines would be directly imported to Taiwan from Germany, Yen said.
Yen denied a rumor that the Tzu Chi Foundation canceled a news conference to announce its vaccine purchase plan after on Monday receiving a call from the Presidential Office.
Chinese Nationalist Party (KMT) Legislator Wen Yu-hsia (溫玉霞) on Monday made the allegation, although the Presidential Office has denied exerting pressure on the Tzu Chi Foundation.
The Tzu Chi Foundation said that it has three reasons for purchasing BioNTech vaccines.
First, it believes that it is the most effective vaccine against COVID-19; second, the manufacturer can supply sufficient doses in an emergency situation; and third, it is the only vaccine on the market that can be administered to 12 to 17-year-olds.
Vaccine import regulations say that applicants must do so through a pharmaceutical company and application must include eight pieces of documentation: plans and methods of execution; a pharmaceutical insert; the amount imported and why the amount was requested; proof of transport and storage at adequate temperatures; the date of vaccine provision; authorization from the original manufacturer; vaccine expiry dates; and proof of pre-market clearance in foreign countries, the Central Epidemic Command Center said last month.
Additional reporting by Wu Liang-yi
ANOTHER EMERGES: The CWA yesterday said this year’s fourth storm of the typhoon season had formed in the South China Sea, but was not expected to affect Taiwan Tropical Storm Gaemi has intensified slightly as it heads toward Taiwan, where it is expected to affect the country in the coming days, the Central Weather Administration (CWA) said yesterday. As of 8am yesterday, the 120km-radius storm was 800km southeast of Oluanpi (鵝鑾鼻), Taiwan’s southernmost tip, moving at 9kph northwest, the agency said. A sea warning for Gaemi could be issued tonight at the earliest, it said, adding that the storm is projected to be closest to Taiwan on Wednesday or Thursday. Gaemi’s potential effect on Taiwan remains unclear, as that would depend on its direction, radius and intensity, forecasters said. Former Weather Forecast
As COVID-19 cases in Japan have been increasing for 10 consecutive weeks, people should get vaccinated before visiting the nation, the Centers for Disease Control (CDC) said. The centers reported 773 hospitalizations and 124 deaths related to COVID-19 in Taiwan last week. CDC Epidemic Intelligence Center Director Guo Hung-wei (郭宏偉) on Tuesday said the number of weekly COVID-19 cases reported in Japan has been increasing since mid-May and surpassed 55,000 cases from July 8 to July 14. The average number of COVID-19 patients at Japan’s healthcare facilities that week was also 1.39 times that of the week before and KP.3 is the dominant
The Chinese Communist Party’s (CCP) working group for Taiwan-related policies is likely to be upgraded to a committee-level body, a report commissioned by the Mainland Affairs Council (MAC) said. As Chinese President Xi Jinping (習近平) is increasingly likely to upgrade the CCP’s Central Leading Group for Taiwan Affairs, Taiwanese authorities should prepare by researching Xi and the CCP, the report said. At the third plenary session of the 20th Central Committee of the CCP, which ended on Thursday last week, the party set a target of 2029 for the completion of some tasks, meaning that Xi is likely preparing to
US-CHINA TRADE DISPUTE: Despite Beijing’s offer of preferential treatment, the lure of China has dimmed as Taiwanese and international investors move out Japan and the US have become the favored destinations for Taiwanese graduates as China’s attraction has waned over the years, the Ministry of Labor said. According to the ministry’s latest income and employment advisory published this month, 3,215 Taiwanese university graduates from the class of 2020 went to Japan, surpassing for the first time the 2,881 graduates who went to China. A total of 2,300 graduates from the class of 2021 went to the US, compared with the 2,262 who went to China, the document showed. The trend continued for the class of 2023, of whom 1,460 went to Japan, 1,334 went to